Glass House Brands Inc. (GLAS)
NYSE: GLAS · Real-Time Price · USD
1.270
+0.020 (1.60%)
At close: Nov 13, 2026, 4:00 PM EST
1.278
+0.008 (0.61%)
After-hours: Nov 13, 2026, 7:59 PM EST
Glass House Brands Market Cap
Glass House Brands has a market cap or net worth of $119.69 million as of November 13, 2026. It is the 23,749th most valuable company in the world and the 3,915th biggest in the United States. Its market cap has decreased by 80.14% in one year.
Market Cap
119.69M
Enterprise Value
173.45M
1-Year Change
-80.14%
Global Rank
Country Rank
#3,915 United States
Category
ChartMarket Cap Chart
Since July 18, 2019, Glass House Brands's market cap has decreased from $430.12M to $119.69M, a decrease of -72.17%. That is a compound annual growth rate of -16.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 119.69M | -83.22% |
| Dec 31, 2025 | 713.12M | 60.28% |
| Dec 31, 2024 | 444.93M | 32.62% |
| Dec 29, 2023 | 335.49M | 156.56% |
| Dec 30, 2022 | 130.77M | -39.88% |
| Dec 31, 2021 | 217.50M | -57.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SIGA Technologies | 207.66M |
| ADC Therapeutics | 198.33M |
| Anika Therapeutics | 184.99M |
| Akebia Therapeutics | 138.28M |
| Organogenesis Holdings | 125.26M |
| Journey Medical | 123.91M |
| Cardiol Therapeutics | 120.45M |
| Organigram Global | 117.69M |